Pharmaceuticals - Greece

  • Greece
  • The Pharmaceuticals market in Greece is expected to achieve a revenue of US$1,616.00m by 2024.
  • Among the various markets, Oncology Drugs is projected to be the largest, with a market volume of US$245.80m in the same year.
  • The market is anticipated to grow at an annual rate of 3.54% (CAGR 2024-2029), resulting in a market volume of US$1,923.00m by 2029.
  • In terms of global comparison, United States is expected to generate the highest revenue, reaching US$630.30bn in 2024.
  • "Greece's pharmaceutical market is experiencing a surge in demand for generic drugs due to the country's economic challenges."

Key regions: United States, China, Germany, Japan, Europe

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Greek Pharmaceuticals market has been experiencing significant growth in recent years.

Customer preferences:
Greek customers are increasingly demanding high-quality pharmaceutical products that are both effective and affordable. They are also looking for products that are easy to access, with a preference for online purchasing. Greek customers are also becoming more health-conscious, leading to an increase in demand for preventive healthcare products.

Trends in the market:
One of the major trends in the Greek Pharmaceuticals market is the increasing use of generic drugs. This trend can be attributed to the Greek government's efforts to reduce healthcare costs by promoting the use of generic drugs. Another trend is the growing demand for over-the-counter (OTC) drugs, which can be purchased without a prescription. This trend is driven by the convenience of purchasing OTC drugs and the increasing availability of these products in pharmacies and online.

Local special circumstances:
The Greek Pharmaceuticals market has been affected by the economic crisis that has been ongoing since 2008. The crisis has led to a reduction in government spending on healthcare, resulting in a decrease in the number of hospitals and healthcare facilities. This has also led to a decrease in the number of healthcare professionals, which has had an impact on the availability of healthcare services in Greece. Additionally, the Greek Pharmaceuticals market has been affected by the country's high level of bureaucracy and regulatory hurdles.

Underlying macroeconomic factors:
One of the key macroeconomic factors driving the growth of the Greek Pharmaceuticals market is the aging population. Greece has one of the highest percentages of elderly people in Europe, which has led to an increase in demand for healthcare products and services. Another factor is the increasing prevalence of chronic diseases, such as diabetes and cardiovascular disease, which has led to a growing demand for pharmaceutical products. Finally, the Greek government's efforts to attract foreign investment and promote economic growth have also had a positive impact on the Pharmaceuticals market.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

Modeling approach / Market size:

Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.

Overview

  • Revenue
  • Analyst Opinion
  • Next generation therapy
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)